Is Alnylam a rare disease company?
Alnylam Publishes Its 1st-Ever Rare Disease Trend Report | Alnylam® Newsroom.
Is Alnylam a good company?
Alnylam Pharmaceuticals is a great company to work for. It is consistently ranked as one of the top companies to work for in Boston. The company is located in Cambridge Massachusetts right by the Kendall/MIT stop.
How do you pronounce Alnylam Pharmaceuticals?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it.
Where is Alnylam based?
Cambridge, Massachusetts
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
How many employees does Alnylam have?
Alnylam has over 1,400 full-time employees worldwide as of March 2020.
When was Onpattro FDA approved?
FDA Approval: 8/10/2018.
Is Alnylam stock a buy?
Alnylam Pharmaceuticals has received a consensus rating of Buy. The company’s average rating score is 2.57, and is based on 8 buy ratings, 6 hold ratings, and no sell ratings.
Is Alnylam public?
When did Alnylam go public? Alnylam started trading publicly in May 2004.
How much does Onpattro cost?
The cost for Onpattro intravenous solution (2 mg/mL) is around $9,928 for a supply of 5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Is Onpattro FDA approved?
The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.
Who is Dr John Maraganore?
Chief Executive Officer Since 2002, Dr. John Maraganore has served as the CEO and a Director of Alnylam. Prior to Alnylam, Dr. Maraganore was a scientist at ZymoGenetics, Inc., and the Upjohn Company.
Who is the CEO of Alnylam, Inc.?
Since 2002, Dr. John Maraganore has served as the CEO and a Director of Alnylam. Prior to Alnylam, Dr. Maraganore served as an officer and a member of the management team for Millennium Pharmaceuticals, Inc.
When did Laurie Bartlett Keating join Alnylam Corporation?
Laurie Bartlett Keating joined Alnylam in 2014 with more than 25 years of executive experience at high-growth technology and biotechnology companies.
Where did dr.alnylam go to medical school?
He completed residency training in Internal Medicine at UCSF, was a fellow in the Robert Wood Johnson Clinical Scholars Program at Johns Hopkins University, and served on the faculty of Harvard Medical School and the Brigham & Women’s Hospital in Boston prior to joining the industry. Dr.
When did dr.pushkal Garg join Alnylam?
Dr. Pushkal Garg joined Alnylam in 2014 with 15 years of experience in clinical drug development. He oversees all clinical development activities at Alnylam. Prior to joining Alnylam, Dr. Garg served as Vice President, Global Clinical Research, Immunoscience at Bristol-Myers Squibb (BMS).